Zentalis Pharmaceuticals, Inc.
$340.37M- Market cap
- $291.70M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 5.05x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · price snapshotP/S 4.33x
$4.07Snapshot Sep 8, 2026, 2:31 PM ET
Implied fair value · at DELL's multiple
$2.8729.5% below market
0.94 ZNTL revenue / share×3.05x DELL P/S=$2.87
Market $4.07Implied $2.87
DELL · price snapshotP/S 3.05x
$533.53Snapshot Sep 8, 2026, 2:32 PM ET
Implied fair value · at ZNTL's multiple
$727.7136.4% above market
168.20 DELL revenue / share×4.33x ZNTL P/S=$727.71
Market $533.53Implied $727.71